Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2005
08/11/2005CA2555763A1 Therapeutic agent for vasospasm accompanying bypass operation
08/11/2005CA2554525A1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
08/11/2005CA2554522A1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
08/11/2005CA2554351A1 Cgrp receptor antagonists
08/11/2005CA2553968A1 Vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain
08/11/2005CA2553433A1 Quinoline quinazoline pyridine and pyrimidine compounds and their use in the treatment of inflammation angiogenesis and cancer
08/11/2005CA2553089A1 Novel piperidines as chemokine modulators (ccr)
08/11/2005CA2552317A1 Hcv ns-3 serine protease inhibitors
08/10/2005EP1561749A1 TNF-Alpha production inhibitors for the treatment of autoimmune diseases
08/10/2005EP1560834A1 New tricyclic derivatives as ltd4 antagonists
08/10/2005EP1560827A1 Anti-infective agents
08/10/2005EP1560825A1 Novel 2,3-dihydro-4(1h)-pyridinone derivatives, method for production thereof and pharmaceutical composition comprising the same
08/10/2005EP1560823A1 4-substituted 1-aminocyclohexane derivatives for utilization as orl1-receptor and mu-opiate receptor ligands
08/10/2005EP1560822A1 4-imidazol-1-ylmethyl-pyrimidine derivatives as ligands for gabaa receptors
08/10/2005EP1560821A2 Antibacterial agents
08/10/2005EP1560820A2 Novel anthranilamide insecticides
08/10/2005EP1560817A1 Methods and compositions of novel triazine compounds
08/10/2005EP1560816A1 Quinazoline derivatives
08/10/2005EP1560815A1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
08/10/2005EP1560811A2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
08/10/2005EP1560584A2 Fab i inhibitors
08/10/2005EP1560580A1 Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors
08/10/2005EP1368340B1 Piperazine derivatives as melanocortin receptor agonists
08/10/2005EP1194425B1 Substituted benzimidazole
08/10/2005EP1086093B1 Tetrahydroquinoline derivatives as glycine antagonists
08/10/2005EP1075262B1 Desmethylpantoprazole compositions and methods
08/10/2005CN1653125A Amelioration of the development of cataracts and other ophthalmic diseases
08/10/2005CN1653061A Process for porducing quinolonecarboxylic acid derivative
08/10/2005CN1653059A Macrocyclic compounds useful as pharmaceuticals
08/10/2005CN1653053A Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
08/10/2005CN1653051A Substituted anthranilamides for controlling invertebrate pests
08/10/2005CN1653050A Opioid and opioid-like compounds and uses thereof
08/10/2005CN1653048A Pyridine carboxamide derivatives and their use as pesticides
08/10/2005CN1653047A Monocyclic aroylpyridinones as antiinflammatory agents
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1653037A Substituted tetracycline compounds
08/10/2005CN1652843A Methods for the treatment of respiratory diseases and conditions using a selective iNOS inhibitor
08/10/2005CN1652792A N3 alkylated benzimidazole derivatives as MEK inhibitors
08/10/2005CN1652787A Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
08/10/2005CN1652784A Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
08/10/2005CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors
08/10/2005CN1652777A Combination of organic compounds
08/10/2005CN1652776A N3 alkylated benzimidazole derivatives as MEK inhibitors
08/10/2005CN1651428A Preparation method of hydrobromic acid antifebrile dichroanone
08/10/2005CN1651392A 2-and 2, 5-substituted phenylketoenols
08/10/2005CN1214029C 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroi-soquinol-2-yl)-5-(2-pyridyl) quinazo line mesylat and polymorphs
08/10/2005CN1214028C Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
08/10/2005CN1214027C Method for obtaining derivatives of [[(pyridil substituted) methyl] thio] benzimidazol
08/10/2005CN1214026C Indol-3-yl derivatives
08/10/2005CN1214025C Sodium channel modulators derived from 2-piperidylimidazoles
08/10/2005CN1214014C HIV inhibiting pyrimidine derivatives
08/10/2005CN1214013C HIV replication inhibiting pyrimidines
08/10/2005CN1214010C 1-aryl pyrazole derivative and its applicance
08/10/2005CN1214004C Process for producing arylsulfenyl halide
08/10/2005CN1213752C Treating allergic and inflammatory diseases
08/10/2005CN1213659C Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and composition containing the same
08/10/2005CN1213658C Picolinamide derivatives and pest controllers containing same as active ingredient
08/09/2005US6927295 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators
08/09/2005US6927293 Tyrosine kinase inhibitors
08/09/2005US6927230 Triazole derivatives
08/09/2005US6927225 Fungicidal 2-pyridyl alkyl amides and their compositions, methods of use and preparation
08/09/2005US6927222 Compounds
08/09/2005US6927214 Non-peptide GLP-1 agonists
08/09/2005CA2327029C Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
08/09/2005CA2188164C Benzamide compounds and pharmaceutical use thereof
08/09/2005CA2105518C Condensed heterocyclic compounds, their production and use
08/04/2005WO2005070934A1 Substituted diazabicycloheptanes and their use as protein kinase inhibitors
08/04/2005WO2005070929A1 Vanilloid receptor ligands and their use in treatments
08/04/2005WO2005070921A1 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids
08/04/2005WO2005070920A1 Amino-benzazoles as p2y1 receptor inhibitors
08/04/2005WO2005070919A1 N-type calcium channel blockers
08/04/2005WO2005070918A1 Process for the preparation of t-11 bicyclic erythromycin derivatives
08/04/2005WO2005070902A1 Therapeutic agents ii
08/04/2005WO2005070899A1 5-phenylpyrimidines and their use as microbicides
08/04/2005WO2005070898A1 Substituted n-cyclohexyl imidazolinones having an mch-modulatory effect
08/04/2005WO2005070893A2 Azadecalin glucocorticoid receptor modulators
08/04/2005WO2005070891A2 Compounds and methods of use
08/04/2005WO2005070430A1 Quinoline derivatives and use thereof as mycobacterial inhibitors
08/04/2005WO2005070133A2 2,6-disubstituted piperidines as modulators of chemokine receptor activity
08/04/2005WO2005069981A2 Method of preparation of benzofuran-2-carboxylic acid {(s)-3-methyl-1-[(4s, 7r)-7methyl-3-oxo-1-(pyridine-2-sulfonyl)-azepan-4-ylcarbamoyl]-butyl}-amide
08/04/2005WO2005054179A3 Hydroxamic acid esters and pharmaceutical use thereof
08/04/2005WO2005051917B1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions
08/04/2005WO2005040355A3 Tao kinase modulators and methods of use
08/04/2005WO2005037199A3 Pyrazole derivatives as cannabinoid receptor modulators
08/04/2005WO2005034867A3 Thioether-substituted benzamides as inhibitors of factor xa
08/04/2005WO2005033048A3 Wnt pathway antagonists
08/04/2005WO2005018557A3 Substituted pyridinones
08/04/2005WO2005000804A3 Substituted indoles and a process for preparing substituted indoles
08/04/2005WO2004091485A3 Aminoquinoline compounds
08/04/2005WO2004075840A9 Selective non-steroidal glucocorticoid receptor modulators
08/04/2005WO2004008837A9 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them
08/04/2005WO2004007457A3 Substituted benzylamine derivatives and methods of use
08/04/2005US20050171366 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde; efficient synthesis of intermediates which are readily amenable to the large scale preparation of hydroxyethylurea-based chiral HIV protease inhibitors
08/04/2005US20050171357 Process for preparing indolinone derivatives
08/04/2005US20050171353 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
08/04/2005US20050171352 Process for the preparation of 4-(8-chloro-5 6-dihydro-11h-benzo-(5 6)-cyclohepta-(1 2b)-pyridin-11-ylidene-1-piperidiniecarboxylic acid ethyl ester (loratadine)
08/04/2005US20050171351 New anthrapyridone compounds, water-base magenta ink compositions and method of ink-jet recording
08/04/2005US20050171347 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/04/2005US20050171346 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections
08/04/2005US20050171188 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
1 ... 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 ... 1080